Email This Article

Headlines & Perspectives
Diabetes-Drug Makers Face FDA Hurdle
By Elizabeth Trotta
11/24/08 - 12:37 PM EST
The regulatory agency is alerting diabetes-drug makers, like Amylin, of new heart-safety data standards.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,380.36 1,103.85 2,186.41 34.76
Oil *
77.91
UP
14.21
UP
3.93
UP
13.27
UP
0.96
10 Yr
3.48%
SPDR Gold
115.04
+0.14%
+0.36%
+0.61%
+2.84%
Data delayed 20 minutes

Brokerage Partners